A
SLRN

AJOVista’s ACELYRIN SLRN Stock Holding History

AJOVista’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$173K Buy
+35,084
New +$181K 0.74% 42

Other funds holding SLRN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

AJOVista's SLRN Position: Q3 2024 in Review

AJOVista opened a new position in ACELYRIN (SLRN) in Q3 2024: 35,084 shares worth $173K. The stake represents 0.74% of the portfolio and ranks #42 among its holdings.

122 funds tracked by Wall St. Rank hold SLRN as of Q3 2024.

  • AJOVista held 35,084 shares of ACELYRIN worth $173K as of Q3 2024.
  • ACELYRIN was a new AJOVista position in Q3 2024.
  • ACELYRIN made up 0.74% of AJOVista's portfolio in Q3 2024, its #42 holding.
  • 122 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.